Please use this identifier to cite or link to this item: https://hdl.handle.net/10356/88448
Full metadata record
DC FieldValueLanguage
dc.contributor.authorTan, Teck Boonen
dc.contributor.authorGunasekaran, Nandhakumaren
dc.date.accessioned2018-04-05T04:38:01Zen
dc.date.accessioned2019-12-06T17:03:33Z-
dc.date.available2018-04-05T04:38:01Zen
dc.date.available2019-12-06T17:03:33Z-
dc.date.issued2018en
dc.identifier.citationTan, T. B., & Gunasekaran, N. (2018). Ketamine Antidepressant : Breakthrough or Potential Hazard?. (RSIS Commentaries, No. 044). RSIS Commentaries. Singapore: Nanyang Technological University.en
dc.identifier.urihttps://hdl.handle.net/10356/88448-
dc.description.abstractMillions of people worldwide suffer from depression. Ketamine has emerged in the West as a promising antidepressant. Its use in depression therapy raises important safety and security questions.en
dc.format.extent3 p.en
dc.language.isoenen
dc.relation.ispartofseriesRSIS Commentaries, 044-18en
dc.rightsNanyang Technological Universityen
dc.subjectCountry and Region Studiesen
dc.subjectEast Asia and Asia Pacificen
dc.titleKetamine Antidepressant : Breakthrough or Potential Hazard?en
dc.typeCommentaryen
dc.contributor.schoolS. Rajaratnam School of International Studiesen
item.grantfulltextopen-
item.fulltextWith Fulltext-
Appears in Collections:RSIS Commentaries
Files in This Item:
File Description SizeFormat 
CO18044.pdf151.39 kBAdobe PDFThumbnail
View/Open

Page view(s)

149
Updated on Sep 18, 2021

Download(s) 5

520
Updated on Sep 18, 2021

Google ScholarTM

Check

Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.